Full Library
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction)
Resource type
Journal Article
Authors/contributors
- Fernández-Ruiz, M. (Author)
- Meije, Y. (Author)
- Manuel, O. (Author)
- Akan, H. (Author)
- Carratalà, J. (Author)
- Aguado, J.M. (Author)
- Delaloye, J. (Author)
Title
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction)
Abstract
Background: The field of new biological agents is increasing exponentially over the past years, thus making prevention and management of associated infectious complications a challenge for nonspecialized clinicians.
Publication
Clinical Microbiology and Infection
Date
06/2018
Volume
24
Pages
S2-S9
Journal Abbr
Clinical Microbiology and Infection
Accessed
6/3/21, 10:15 AM
ISSN
1198743X
Short Title
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Fernández-Ruiz, M., Meije, Y., Manuel, O., Akan, H., Carratalà, J., Aguado, J. M., & Delaloye, J. (2018). ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction). Clinical Microbiology and Infection, 24, S2–S9. https://doi.org/10.1016/j.cmi.2018.01.029
GUIDELINES
HEME-ONC AND CELLULAR THERAPIES
Link to this record